The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> Analyst Interviews >> March 11, 2016

Value-Based Reimbursement and Increased Consumerism Drive Health Care IT Revolution

Hooker, Donald
Donald Hooker, CFA, is a Vice President, Equity Research Analyst with KeyBanc Capital Markets Inc. With the company since 2013, his research coverage is focused on health care IT, biopharmaceuticals and laboratory companies. Prior to joining KBCM, Mr. Hooker worked at Morgan Stanley as a Research Analyst covering the health care information sector. Previous equity research experience includes working as a health care services, IT and facilities analyst for UBS Securities. Mr. Hooker graduated from the College of Wooster with a Bachelor of Arts in economics. He is a Chartered Financial Analyst and holds the Series 7, 63, 86 and 87 industry licenses. Mr. Hooker is also a member of the CFA Institute and the New York Society of Security Analysts — NYSSA. In its May 2016 Analyst Awards, Thomson Reuters recognized Mr. Hooker as the number one stock picker in the life science tools and services sector. This was Mr. Hooker’s second Thomson Reuters Analyst Award. In 2008, Mr. Hooker was recognized by The Wall Street Journal’s Best on the Street survey in the HCIT category. Profile
TWST: We had a lot of press around health IT when the Affordable Care Act was being debated and implemented. Has the space settled down now that the ACA is in place?

Mr.

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy